Gene · 2243
Papers3,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroinflammation Markers in Tear Fluid of Mild Alzheimer's Disease. | J Mol Neurosci | 2025 | 40471493 | PubTator, text mining | PubMed |
| The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case-control study in southern Iran. | Blood Coagul Fibrinolysis | 2025 | 40464840 | PubTator, text mining | PubMed |
| Unveiling the dynamic drivers: phase separation's pivotal role in stem cell biology and therapeutic potential. | Stem Cell Res Ther | 2025 | 40442783 | PubTator, text mining | PubMed |
| Association of matrix metalloproteinase 7 and the alpha-chain of fibrinogen at baseline with response to methotrexate at 3 months in patients with early rheumatoid arthritis. | BMC Rheumatol | 2025 | 40400044 | PubTator, text mining | PubMed |
| FGA can be used as a promising therapeutic target in osteoarthritis. | BMC Musculoskelet Disord | 2025 | 40394574 | PubTator, text mining | PubMed |
| A comparative experimental study on the collection and analysis of DNA samples from under-fingernail materials. | Forensic Sci Res | 2025 | 40385618 | PubTator, text mining | PubMed |
| Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis. | Genomics Inform | 2025 | 40375318 | PubTator, text mining | PubMed |
| [Clinical characteristics and genotypes of patients with Congenital fibrinogen disorders]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 40372216 | PubTator, text mining | PubMed |
| Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers. | NPJ Precis Oncol | 2025 | 40369102 | PubTator, text mining | PubMed |
| Comprehensive identification of stone-promoting proteins in the urine of kidney stone formers. | Int J Biol Macromol | 2025 | 40253023 | PubTator, text mining | PubMed |
| GeneSetCart: assembling, augmenting, combining, visualizing, and analyzing gene sets. | Gigascience | 2025 | 40208796 | PubTator, text mining | PubMed |
| Identifying diagnostic markers and establishing prognostic model for lung cancer based on lung cancer-derived exosomal genes. | Cancer Biomark | 2025 | 40179422 | PubTator, text mining | PubMed |
| Pathogenic Mechanisms in Congenital Afibrinogenemia: A Systematic Review of Genetic Variants. | Haemophilia | 2025 | 40099427 | PubTator, text mining | PubMed |
| Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma. | Front Immunol | 2025 | 40098956 | PubTator, text mining | PubMed |
| Congenital Fibrinogen Deficiencies: Not So Rare. | Hamostaseologie | 2025 | 40074015 | PubTator, text mining | PubMed |
| Development and Validation of the 9-Dye Fluorescent Autosomal and Y Chromosome Multiplex STR Amplification System. | Electrophoresis | 2025 | 40047268 | PubTator, text mining | PubMed |
| STR profiling in a cohort of Saudi patients with acute leukemia. | J Taibah Univ Med Sci | 2025 | 40026413 | PubTator, text mining | PubMed |
| [Molecular Pathogenic Mechanism Study of Two Cases of Inherited Dysfibrinogenemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40017205 | PubTator, text mining | PubMed |
| Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses. | Int J Mol Sci | 2025 | 39940778 | PubTator, text mining | PubMed |
| Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA). | Amyloid | 2025 | 39928315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2243/papers?page=6